Summary of Key Points from Conference Call Records Industry Overview - The conference call focuses on the brain-computer interface (BCI) industry, highlighting recent advancements and developments in the field of medical technology related to brain-machine interfaces and rehabilitation robotics. Core Insights and Arguments 1. The release of the "Clinical Application Path Management Expert Consensus for Implantable Brain-Computer Interfaces (2026 Edition)" led by Academician Zhao Jizong aims to promote the scientific, safe, and orderly development of iBCI clinical translation [1] 2. The Ministry of Civil Affairs issued guidelines to advance technological innovation in civil affairs, emphasizing the application of humanoid robots, brain-computer interfaces, and artificial intelligence in various areas such as disability prevention, elderly care, and rehabilitation [1][2] 3. Neuralink announced that its first brain-computer interface product, "Telepathy," has enrolled 21 patients in clinical trials [1] 4. Qiangnao Technology launched a medical-grade product "Zhuanzhuo Xin" for children with ADHD, which consists of rehabilitation training software and a single-channel EEG collector, both of which have received Class II medical device registration from the National Medical Products Administration [1] 5. Fourier, an early player in the rehabilitation robotics industry, plans to introduce brain-computer interface solutions integrated with embodied intelligence for rehabilitation [1] 6. Fudan University and Huashan Hospital's neurosurgery department released clinical trial data on the "UltraBrainPad," a domestically developed ultrasound diagnostic and therapeutic device that opens the blood-brain barrier for glioblastoma patients, significantly increasing drug concentration in the brain [2] 7. Ybrain is recruiting former executives from Samsung Electronics and VUNO to promote a non-oral antidepressant based on tDCS and EEG technology, aiming to create an AI mental health ecosystem [2] 8. Neofect, a South Korean digital healthcare company, announced a collaboration with the HanDe Consortium to commercialize brain-computer interfaces, focusing on developing a brain-controlled rehabilitation robot system for stroke patients over a 36-month period [2] Additional Important Content - Future attention is recommended on the release of the 14th Five-Year Plan post the Two Sessions, upcoming approvals for invasive products, IPO filings from brain-machine companies, and clinical data releases from leading companies [2] - Investment suggestions include focusing on companies such as Aipeng Medical, Xiangyu Medical, Innovation Medical, Meihao Medical, Kefu Medical, Mailande, Weisi Medical, Sanbo Brain Science, Yanshan Technology, Chengyitong, and Lepu Medical, as well as potential IPO candidates like Qiangnao Technology and Borui Kang [2] - Risk factors highlighted include policy changes and the risk of commercialization of products or services not meeting expectations [3]

行 机械设备 2026 年 01 月 31 日 业 研 究 机械设备 超声脑机接口启新篇，中国方案破解脑病治疗困局 投资要点： "十五五"重点赛道，脑机接口市场规模有望快速增长 根据 precedence research，2024 年全球脑机接口市场规模约为 26.2 亿美元，预计 2025 年将达到 29.4 亿美元，到 2034 年有望增长至 124 亿美元，十年间复合年增长率为 17.35%；据工信微报，2024 年中国脑 机接口市场规模为 32.0 亿元，预计到 2028 年将达 61.4 亿元。《中共 中央关于制定国民经济和社会发展第十五个五年规划的建议》提出前 瞻布局未来产业，推动脑机接口等成为新的经济增长点。这些产业蓄 势发力，未来 10 年将再造一个中国高技术产业。 建议关注 岩山科技、汉威科技、三博脑科、创新医疗、东方中科、翔宇医 疗、熵基科技、诚益通、伟思医疗、麦澜德、爱朋医疗、倍益康等。 风险提示 证 市场竞争加剧、政策支持力度不及预期、技术研发及新产品开发 不利、脑机产品造成病患受伤等风险 技术突破创新，超声精准打开血脑屏障 行 业 定 期 报 告 近日，复旦大学联合华山医院在国家重 ...

行 机械设备 2026 年 01 月 31 日 业 研 究 机械设备 超声脑机接口启新篇，中国方案破解脑病治疗困局 投资要点： 技术突破创新，超声精准打开血脑屏障 行 业 定 期 报 告 近日，复旦大学联合华山医院在国家重点研发计划项目启动会上， 发布国内首例采用自主研制超声诊疗一体化装置"UltraBrainPad"的临 床试验成果。该半侵入式技术为全球第三种方案，通过手持式探头结 合 AI 图像识别，3 分钟即可打开胶质母细胞瘤患者血脑屏障，药物浓 度平均提升 8 倍，6 小时后屏障自动关闭，操作便捷、成本可控且安全 性优于国际水平，成功破解传统技术感染风险高、精度不足等难题。 赛道拓展赋能，惠及多种脑病治疗场景 作为国家重点研发计划项目，该技术已启动复发胶质母细胞瘤临 床研究，未来将打造超声脑机接口新赛道。除脑肿瘤药物治疗外，其 科研成果还将向神经调控、脑机融合方向转化，有望为阿尔兹海默病、 头痛、失眠等多种脑病提供全新治疗路径，凭借基层可及的优势，让 更多患者受益于这一"中国方案"。 岩山科技、汉威科技、三博脑科、创新医疗、东方中科、翔宇医 疗、熵基科技、诚益通、伟思医疗、麦澜德、爱朋医疗、倍益康等。 ...